Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

686 ARTÍCULOS , VIENDO DEL 571 AL 585

Conversion between the Montreal Cognitive Assessment and the Mini-Mental Status Examination

Fasnacht JS, Wueest AS, Berres M, Thomann AE, Krumm S, Gutbrod K, Steiner LA, Goettel N, Monsch AU.

J Am Geriatr Soc. 2023 Mar;71(3):869-879. doi: 10.1111/jgs.18124. Epub 2022 Nov 8.

Clinical Reasoning: Rapidly Progressive Dementia in a Man With HIV Infection and Undetectable Plasma Viral Load

Chishimba LC, Chomba M, Zimba S, Asukile MT, Makai O, Saylor DR.

Neurology. 2023 Feb 14;100(7):344-348. doi: 10.1212/WNL.0000000000201576. Epub 2022 Nov 8.

The effects of synthetic glucocorticoid treatment for inflammatory disease on brain structure, function, and dementia outcomes: A systematic review

Shorey CL, Mulla RT, Mielke JG.

Brain Res. 2023 Jan 1;1798:148157. doi: 10.1016/j.brainres.2022.148157. Epub 2022 Nov 8.

Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose

Chen XQ, Zuo X, Becker A, Head E, Mobley WC.

Alzheimers Dement. 2023 May;19(5):2095-2116. doi: 10.1002/alz.12835. Epub 2022 Nov 12.

Can dementia risk be reduced by following the American Heart Association's Life's Simple 7? A systematic review and dose-response meta-analysis

Wu J, Xiong Y, Xia X, Orsini N, Qiu C, Kivipelto M, Rizzuto D, Wang R.

Ageing Res Rev. 2023 Jan;83:101788. doi: 10.1016/j.arr.2022.101788. Epub 2022 Nov 9.

Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome

Ganguly BB, Kadam NN.

Mitochondrion. 2023 Jan;68:25-43. doi: 10.1016/j.mito.2022.11.003. Epub 2022 Nov 9.

A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia

Aarsland D, Khalifa K, Bergland AK, Soennesyn H, Oppedal K, Holteng LBA, Oesterhus R, Nakling A, Jarholm JA, de Lucia C, Fladby T, Brooker H, Dalen I, Ballard C.

Am J Geriatr Psychiatry. 2023 Feb;31(2):141-151. doi: 10.1016/j.jagp.2022.10.002. Epub 2022 Oct 18.

Quality of life measurement tools for people with dementia and intellectual disabilities: A systematic review

Tsang W, Oliver D, Triantafyllopoulou P.

J Appl Res Intellect Disabil. 2023 Jan;36(1):28-38. doi: 10.1111/jar.13050. Epub 2022 Nov 15.

A review on Alzheimer's disease classification from normal controls and mild cognitive impairment using structural MR images

Garg N, Choudhry MS, Bodade RM.

J Neurosci Methods. 2023 Jan 15;384:109745. doi: 10.1016/j.jneumeth.2022.109745. Epub 2022 Nov 14.

Circadian Rhythm Changes in Healthy Aging and Mild Cognitive Impairment

Keihani A, Mayeli A, Ferrarelli F.

Adv Biol (Weinh). 2023 Nov;7(11):e2200237. doi: 10.1002/adbi.202200237. Epub 2022 Nov 20.

The effects of time-restricted eating on sleep, cognitive decline, and Alzheimer's disease

Ezzati A, Pak VM.

Exp Gerontol. 2023 Jan;171:112033. doi: 10.1016/j.exger.2022.112033. Epub 2022 Nov 17.

The Burden of Dementia Spectrum Disorders and Associated Comorbid and Demographic Features

Sabayan B, Wyman-Chick KA, Sedaghat S.

Clin Geriatr Med. 2023 Feb;39(1):1-14. doi: 10.1016/j.cger.2022.07.001. Epub 2022 Oct 21.

Vascular and Nonvascular Mechanisms of Cognitive Impairment and Dementia

Kara B, Gordon MN, Gifani M, Dorrance AM, Counts SE.

Clin Geriatr Med. 2023 Feb;39(1):109-122. doi: 10.1016/j.cger.2022.07.006. Epub 2022 Oct 18.

The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention

Mahinrad S, Sorond F, Gorelick PB.

Clin Geriatr Med. 2023 Feb;39(1):123-134. doi: 10.1016/j.cger.2022.07.007. Epub 2022 Oct 18.

Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias

Perlett L, Smith EE.

Clin Geriatr Med. 2023 Feb;39(1):135-149. doi: 10.1016/j.cger.2022.07.008. Epub 2022 Oct 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias